HomeFBLG • NASDAQ
add
Fibrobiologics Inc
Previous close
$2.84
Day range
$2.68 - $3.00
Year range
$1.08 - $55.00
Market cap
97.39M USD
Avg Volume
662.27K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.22M | 54.04% |
Net income | 898.00K | 141.57% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.19M | -52.42% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 5.97M | -47.50% |
Total assets | 8.91M | -35.63% |
Total liabilities | 11.30M | 353.59% |
Total equity | -2.39M | — |
Shares outstanding | 35.16M | — |
Price to book | -40.57 | — |
Return on assets | -79.37% | — |
Return on capital | 699.05% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | 898.00K | 141.57% |
Cash from operations | -1.95M | -19.82% |
Cash from investing | -66.00K | -175.00% |
Cash from financing | -172.00K | 89.96% |
Net change in cash | -2.18M | 35.01% |
Free cash flow | -4.83M | — |
About
Founded
2021
Headquarters
Website
Employees
10